Dec 29 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Expedia Group, Hasbro and Palisade Bio on Monday.
HIGHLIGHTS
* Expedia Group Inc EXPE.O: Argus Research raises target price to $340 from $300
* Hasbro Inc HAS.O: Jefferies raises target price to $95 from $90
* Palisade Bio Inc PALI.O: Piper Sandler initiates coverage with overweight rating
* Praxis Precision Medicines Inc PRAX.O: BTIG raises target price to $843 from $507
* Vail Resorts Inc MTN.N: Truist Securities cuts target price to $234 from $237
Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock entries are in alphabetical order.
* Amicus Therapeutics Inc FOLD.O: Leerink Partners cuts target price to $14.50 from $17
* Amicus Therapeutics Inc FOLD.O: Leerink Partners cuts to market perform from outperform
* BP BP.N: Gerdes Energy Research cuts target price by $1 to $48
* Citigroup C.N: Piper Sandler raises target price to $130 from $120
* Expedia Group Inc EXPE.O: Argus Research raises target price to $340 from $300
* Hasbro Inc HAS.O: Jefferies raises target price to $95 from $90
* Palisade Bio Inc PALI.O: Piper Sandler initiates coverage with overweight rating
* Palisade Bio Inc PALI.O: Piper Sandler initiates coverage with price target $25
* Praxis Precision Medicines Inc PRAX.O: BTIG raises target price to $843 from $507
* Vail Resorts Inc MTN.N: Truist Securities cuts target price to $234 from $237
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
